Table 2.
Adjuvant chemotherapy regimens used in our study.
| Regimen | Percentage |
|---|---|
| FEC100 +Paclitaxel, n (%) | 48 (72%) |
| FEC100 +Docetaxel, n (%) | 5 (8%) |
| FEC100, n (%) | 10 (15%) |
| EC n (%) | 3 (5%) |
Adjuvant chemotherapy regimens used in our study.
| Regimen | Percentage |
|---|---|
| FEC100 +Paclitaxel, n (%) | 48 (72%) |
| FEC100 +Docetaxel, n (%) | 5 (8%) |
| FEC100, n (%) | 10 (15%) |
| EC n (%) | 3 (5%) |